Clinical Trial Update: Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating network connectivity and inhibitory control under atomoxetine challenge in patients with ADHD; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: RWTH Aachen University | Conditions: ADHD | Phase 4 | Status: COMPLETED